Learn how we're pioneering a new wave of precision medicine, explore our collection of publications, disease studies, webinars, thought leadership, and more
Extending precision medicine into neurological, psychiatric, and neurodegenerative diseases
Cross-Disorder Patient and Mechanistic Stratification using Combinatorial Analyses
Our analyses indicate that subgroups of patients with CNS diseases have common pathophysiological drivers that may contribute to specific common clinical manifestations.
Combinatorial Analysis of ALS and FTD Patient Genomes to Identify Cross-Disease Mechanisms
Our analyses provides insights into subgroups of patients with ALS and FTD with common pathophysiological drivers that may underlie specific overlapping clinical manifestations, allowing us to develop precision medicine interventions targeted at mechanisms occurring in both diseases.
Patient Stratification of Asthma Population Reveals Distinct Genetic & Mechanistic Differences between T2-High and T2-Low Asthma
The PrecisionLife platform identified 2,483 SNPs that were highly associated with T2-high asthma and 1,182 SNPs in the T2-low cohort with only 36 common between the two datasets.
Alzheimer's Disease Study
Understanding disease mechanisms to identify novel targets and patient stratification biomarkers - improving the probability of future clinical trial success in Alzheimer's disease
How can mechanistic patient stratification inform R&D in complex chronic diseases?
Groundbreaking disease biology and drug discovery insights revealed by stratifying patients using combinatorial analytics